Prince Pharmaceutical Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,056	690.03	753.33	712.53	441.08
Revenue Growth (YoY)	53.07%	-8.40%	5.73%	61.54%	49.12%
Cost of Revenue	833.65	615.75	600.23	506.74	315.59
Gross Profit	222.55	74.28	153.09	205.79	125.49
Selling, General & Admin	77.04	75.43	72.74	65.9	47.38
Research & Development	34.64	48.2	54.67	72.05	79.21
Operating Expenses	111.68	123.63	127.31	138.03	126.6
Operating Income	110.87	-49.35	25.78	67.76	-1.11
Interest Expense	-9.58	-10.27	-10.46	-8.94	-7.55
Interest & Investment Income	0.9	1.3	1.16	0.22	0.03
Currency Exchange Gain (Loss)	-	-	-	4.18	-1
Other Non Operating Income (Expenses)	2.55	6.38	2.63	0.92	-0.76
EBT Excluding Unusual Items	104.74	-51.95	19.11	64.14	-10.4
Gain (Loss) on Sale of Assets	-	-0.14	0.06	0.06	0.09
Pretax Income	104.74	-52.08	19.17	64.2	-10.31
Income Tax Expense	8.42	1.46	3.86	12.65	-2.01
Net Income	96.32	-53.54	15.31	51.55	-8.3
Net Income to Common	96.32	-53.54	15.31	51.55	-8.3
Net Income Growth	-	-	-70.30%	-	-
Shares Outstanding (Basic)	37	37	36	33	33
Shares Outstanding (Diluted)	37	37	37	33	33
Shares Change (YoY)	0.89%	0.09%	9.66%	0.41%	1.45%
EPS (Basic)	2.62	-1.46	0.43	1.55	-0.25
EPS (Diluted)	2.61	-1.46	0.42	1.55	-0.25
EPS Growth	-	-	-72.90%	-	-
Free Cash Flow	71.81	28.21	0.45	72.13	1.38
Free Cash Flow Per Share	1.95	0.77	0.01	2.16	0.04
Dividend Per Share	-	-	0.250	0.150	-
Dividend Growth	-	-	66.67%	-	-
Gross Margin	21.07%	10.76%	20.32%	28.88%	28.45%
Operating Margin	10.50%	-7.15%	3.42%	9.51%	-0.25%
Profit Margin	9.12%	-7.76%	2.03%	7.23%	-1.88%
Free Cash Flow Margin	6.80%	4.09%	0.06%	10.12%	0.31%
EBITDA	172.48	4.54	75.94	113.7	40.05
EBITDA Margin	16.33%	0.66%	10.08%	15.96%	9.08%
D&A For EBITDA	61.61	53.89	50.16	45.93	41.16
EBIT	110.87	-49.35	25.78	67.76	-1.11
EBIT Margin	10.50%	-7.15%	3.42%	9.51%	-0.25%
Effective Tax Rate	8.04%	-	20.12%	19.70%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.